351 related articles for article (PubMed ID: 30417469)
21. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus: a meta-analysis].
Xu HX; Wang LJ; Yu YX; Wu YP; Xu YF; Liu XX; Chen Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):755-60. PubMed ID: 23207336
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
24. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Xu J; Tao LL; Ma LX
J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
[TBL] [Abstract][Full Text] [Related]
25. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.
Tavakolpour S; Darvishi M; Mirsafaei HS; Ghasemiadl M
Infect Dis (Lond); 2018 Feb; 50(2):95-106. PubMed ID: 29020844
[TBL] [Abstract][Full Text] [Related]
26. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
[TBL] [Abstract][Full Text] [Related]
28. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
Yang Q; Zhong Z; Yang Y; Ma Y; Flomo KT
Gastroenterol Hepatol; 2020 Dec; 43(10):640-648. PubMed ID: 32948358
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
Ding Y; Cao L; Zhu L; Huang Y; Lin C; Wang Y; Liu Y; Sheng Q; Wang S; Fan J; Chen R; Gan W; Chen B; Pan CQ
Aliment Pharmacol Ther; 2020 Oct; 52(8):1377-1386. PubMed ID: 32852100
[TBL] [Abstract][Full Text] [Related]
31. Chronic HBV: which pregnant women should be treated?
He T; Jia J
Liver Int; 2016 Jan; 36 Suppl 1():105-8. PubMed ID: 26725906
[TBL] [Abstract][Full Text] [Related]
32. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.
Brown RS; McMahon BJ; Lok AS; Wong JB; Ahmed AT; Mouchli MA; Wang Z; Prokop LJ; Murad MH; Mohammed K
Hepatology; 2016 Jan; 63(1):319-33. PubMed ID: 26565396
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
[TBL] [Abstract][Full Text] [Related]
34. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
[TBL] [Abstract][Full Text] [Related]
35. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
Han GR; Jiang HX; Wang CM; Ding Y; Wang GJ; Yue X; Zhou L; Zhao W
J Viral Hepat; 2017 Jun; 24(6):514-521. PubMed ID: 28039902
[TBL] [Abstract][Full Text] [Related]
36. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
[TBL] [Abstract][Full Text] [Related]
37. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Wang M; Ran R; Zhu Y; Zhang H
Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
[TBL] [Abstract][Full Text] [Related]
39. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
